The global FMS-Like Tyrosine kinase 3 (FLT3) inhibitors market size reached USD 405.6 Million in 2021 and is expected to reach USD 1395.7 Million in 2030 registering a CAGR of 14.6%. FMS-Like Tyrosine kinase 3 (FLT3) inhibitors market growth is primarily driven owing to increasing approvals of FLT3 inhibitor drugs and rising incidence of Acute Myeloid Leukemia (AML)